Notes from the Silk Road: Xtep Int’l Holdings (1368 HK): Should We Continue to Step Away?
We have moved to review our stance and numbers around Xtep. Certainly, half-year numbers could provide evidence of a more positive stance to be...
339 Views
China Feihe (中国飞鹤) IPO Trading - Allocation, Peer Performance, and Upside
China Feihe, the largest domestic infant milk formula (IMF) player, raised USD 847 million at HKD 7.50 per share. In this insight, we will cover...
480 Views
China Feihe: Trading Debut, Valuation Scenario Analysis
China Feihe (6186 HK) will commence trading on Wednesday, 13 November. Feihe priced its IPO at HK$7.50 per share (at the low-end of the range). The...
469 Views
China Feihe IPO: Valuation Is Good for You
China Feihe (FEIHE HK) is the leading player in the China IMF (infant milk formula) market as measured by retail sales value in 2018, according to...
455 Views
China Feihe (中国飞鹤) IPO - Wide Valuation Range, No Cornerstone, and Things to Note
China Feihe has started book building to raise up to USD 1.1 billion to list in Hong Kong. In our previous insight, we have discussed the company’s...
534 Views